GlassScriptPhysician profile
Christopher H Dyas
NPI 1730297961
$18,468.44
in general payments reported to CMS, 2019-2025
19 companies · $440 in 2025
The $440 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,374 · 2020: $280 · 2021: $4,407 · 2022: $5,280 · 2023: $456 · 2024: $6,232 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,913 · Food and Beverage: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,912.93 |
| Food and Beverage | $1,214.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,918.54 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $1,860.53 | 2024 | Signia, Ligasure |
| Tela Bio, INC. | $144.40 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Lexington Medical, INC. | $89.37 | 2021 | |
| Covidien LP | $87.65 | 2020 | |
| Davol INC. | $70.06 | 2021-2023 | Phasix Mesh |
| Innocoll Pharmaceuticals Limited | $48.06 | 2023 | Xaracoll |
| Trevena, INC. | $44.51 | 2022-2023 | Olinvyk |
| W. L. Gore & Associates, INC. | $34.01 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.87 | 2022 | |
| Veracyte, INC. | $22.38 | 2023 | |
| Endogastric Solutions, INC | $21.56 | 2023 | Esophyx |
| Mallinckrodt Hospital Products INC. | $21.19 | 2021 | |
| Novo Nordisk INC | $16.97 | 2022 | |
| Kerecis Limited | $14.62 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $13.12 | 2019 | |
| Myriad Genetic Laboratories, INC. | $12.70 | 2021 | |
| Ethicon US, LLC | $12.22 | 2021 | |
| Allergan, INC. | $11.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Dyas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.